M059 A DELAYED GENERALIZED RASH AFTER FIRST MRNA-COVID-19 VACCINATION: TO VACCINATE OR NOT TO VACCINATE AGAIN

por Avila, K., Carrillo-Martin, I., Hobbs, M., Gonzalez-Estrada, A.
Publicado 2021

The development and validation of a nationwide dataset of water distribution zones in Aotearoa New Zealand: A cross-sectional geospatial study

por Puente-Sierra, M., Chambers, T., Marek, L., Broadbent, J.M., O'Brien, B., Hobbs, M.
Publicado 2023

Empowering community control over alcohol availability as a suicide and self-harm prevention measure: Policy opportunity in Aotearoa New Zealand

por Boden, J., Hetrick, S., Bowden, N., Fortune, S., Marek, L., Theodore, R., Ruhe, T., Kokaua, J., Hobbs, M.
Publicado 2022

DSM-IV post-traumatic stress disorder among World Trade Center responders 11–13 years after the disaster of 11 September 2001 (9/11)

por Bromet, E. J., Hobbs, M. J., Clouston, S. A. P., Gonzalez, A., Kotov, R., Luft, B. J.
Publicado 2016

Access and quality of parks and associations with obesity: A cross-sectional study

por Hobbs, M., Green, Mark A., Griffiths, C., Jordan, H., Saunders, J., Grimmer, H., McKenna, J.
Publicado 2017

1366P Impact of COVID-19 on prostate cancer diagnosis and treatment

por Leszczynski, R.L., Norori, N., Beecroft, S., Wallace, J., Levick, B., Hobbs, M.D., Harding, T., Hall, G.
Publicado 2022

Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005

por Briffa, Tom, Hickling, S, Knuiman, M, Hobbs, M, Hung, J, Sanfilippo, F M, Jamrozik, K, Thompson, P L
Publicado 2009

Investigating the transmission risk of infectious disease outbreaks through the Aotearoa Co-incidence Network (ACN): a population-based study

por Turnbull, S.M., Hobbs, M., Gray, L., Harvey, E.P., Scarrold, W.M.L., O'Neale, D.R.J.
Publicado 2022

SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink

por Carr, D F, O'Meara, H, Jorgensen, A L, Campbell, J, Hobbs, M, McCann, G, van Staa, T, Pirmohamed, M
Publicado 2013

Evaluation of long-term clinical and health service outcomes following coronary artery revascularisation in Western Australia (WACARP): a population-based cohort study protocol

por Gardner, C, Rankin, J M, Geelhoed, E, Nguyen, M, Newman, M, Cutlip, D, Knuiman, M W, Briffa, T G, Hobbs, M S T, Sanfilippo, F M
Publicado 2014

Progress Towards Using Linked Population-Based Data For Geohealth Research: Comparisons Of Aotearoa New Zealand And The United Kingdom

por Oldroyd, R. A., Hobbs, M., Campbell, M., Jenneson, V., Marek, L., Morris, M. A., Pontin, F., Sturley, C., Tomintz, M., Wiki, J., Birkin, M., Kingham, S., Wilson, M.
Publicado 2021

P884: POTENTIAL BENEFIT OF POST-TRANSPLANT DOXYCYCLINE IN AL ACHIEVING HEMATOLOGICAL RESPONSE AFTER AUTOLOGOUS STEM CELL TRANSPLANT – LONG TERM FOLLOW UP

por Abdallah, N., Dispenzieri, A., Muchtar, E., Buadi, F., Kapoor, P., Lacy, M., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Leung, N., Dingli, D., Go, R., Lin, Y., Gonsalves, W., Binder, M., Kourelis, T., Warsame, R., Kyle, R., Rajkumar, S., Gertz, M., Kumar, S.
Publicado 2022

P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE

por Vaxman, I., Kumar, S., buadi, F., Lacy, M., Dingli, D., Fonder, A., Hobbs, M., Hayman, S., hwa, L. Y., Kouralis, T., Warsame, R., Muchtar, E., Nelson, L., Kapoor, P., Grogan, M., Go, R., Gonsalves, W., Siddiqi, M., Robert, K., Rajkumar, V., Gertz, M., Dispenzieri, A.
Publicado 2022

Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience

por Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hayman, S., Kourelis, T., Warsame, R., Hwa, Y., Fonder, A., Hobbs, M., Muchtar, E., Leung, N., Kapoor, P., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., Gertz, M. A., Dispenzieri, A.
Publicado 2023

Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design

por Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Kourelis, T., Warsame, R., Muchtar, E., Leung, N., Kapoor, P., Grogan, M., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., Gertz, M. A., Dispenzieri, A.
Publicado 2021

“Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience

por Vaxman, I., Abeykoon, J., Dispenzieri, A., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hwa, Y., Fonder, A., Hobbs, M., Reeder, C., Sher, T., Hayman, S., Kourelis, T., Warsame, R., Muchtar, E., Leung, N., Go, R., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., Kristen, McCullough, Kapoor, P., Gertz, M. A.
Publicado 2021

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

por Tandon, N, Rajkumar, S V, LaPlant, B, Pettinger, A, Lacy, M Q, Dispenzieri, A, Buadi, F K, Gertz, M A, Hayman, S R, Leung, N, Go, R S, Dingli, D, Kapoor, P, Lin, Y, Hwa, Y L, Fonder, A L, Hobbs, M A, Zeldenrust, S R, Lust, J A, Gonsalves, W I, Russell, S J, Kumar, S K
Publicado 2017